Germany Proposes Easing Cannabis Finished-Medicine Priority Rules, Without Restoring Flower Reimbursement
After July reform and conflicting August interpretations, Germany's coalition proposed limiting the priority trial to a finished medicine's approved indications. It does not generally restore flower reimbursement. The October 6 report preceded committee consideration and does not confirm enactment or a nationwide rule from later unverified court coverage.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
businessofcannabis.com
CannabisInsight selects and summarizes news from external sources. Copyright in the original articles remains with the respective publishers or institutions. Follow the source links for full reporting and context.
Original Link
https://businessofcannabis.com/germany-to-soften-cannabis-insurance-reforms-as-exilby-lobbying-row-escalates/